Abbott's uninterrupted streak: 398th consecutive quarterly dividend declared
The board of directors of Abbott Laboratories (Pty) Ltd recently declared a quarterly common dividend of USD 51 cents per share.
Source: Supplied.
This marks the 398th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable by 15 August 2023, to shareholders of record at the close of business on 14 July 2023.
Abbott has increased its dividend payout for 51 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.
Abbott’s portfolio of technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Its 115,000 colleagues serve people in more than 160 countries.
Abbott Laboratories South Africa is headquartered in Gauteng.
Related
Africa’s healthcare funding crisis: 3 strategies to manage deadly diseases 24 Apr 2025 New HIV prevention drug could reach poorest countries by 2025, says health official 18 Dec 2024 Viatris invests R100m in Isando to increase local ARV manufacturing 4 Dec 2024 HIV: there’s hope for a cure – where we stand now 3 Dec 2024 ARV supply set to triple: South Africa's new plan to tackle HIV 2 Dec 2024 The Aids Healthcare Foundation rolls out in Mpumalanga 20 Nov 2024
